Back
Heron Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15
HRTX
Heron Therapeutics, Inc.
Last Price:
$0.79
Seasonality Move:
-6.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and HRTX is experiencing slight buying pressure.
Heron Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.79 | Buy |
| 20-day SMA: | 0.85 | Sell |
| 50-day SMA: | 1.09 | Sell |
| 200-day SMA: | 1.36 | Sell |
| 8-day EMA: | 0.78 | Buy |
| 20-day EMA: | 0.64 | Buy |
| 50-day EMA: | 0.39 | Buy |
| 200-day EMA: | 0.12 | Buy |
Heron Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 36.07 | Sell |
| Chaikin Money Flow: | 470863 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.77 - 1.05) | Sell |
| Bollinger Bands (100): | (0.97 - 1.37) | Sell |
Heron Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Heron Therapeutics, Inc. Stock
Is Heron Therapeutics, Inc. Stock a Buy?
-
Heron Therapeutics, Inc. share price is 0.80 while HRTX 8-day simple moving average is 0.79, which is a Buy signal.
-
The stock price of HRTX is 0.80 while Heron Therapeutics, Inc. 20-day SMA is 0.85, which makes it a Sell.
-
Heron Therapeutics, Inc. 50-day simple moving average is 1.09 while HRTX share price is 0.80, making it a Sell technically.
-
HRTX stock price is 0.80 and Heron Therapeutics, Inc. 200-day simple moving average is 1.36, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
15
Heron Therapeutics, Inc. (HRTX)
is a Sell
Is Heron Therapeutics, Inc. a Buy or a Sell?
-
Heron Therapeutics, Inc. stock is rated a SellThe current Heron Therapeutics, Inc. [HRTX] share price is $0.80. The Score for HRTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics, Inc. Stock Info
Market Cap:
149M
Price in USD:
0.80
Share Volume:
904.1K
Heron Therapeutics, Inc. 52-Week Range
52-Week High:
2.61
52-Week Low:
0.74
Sell
15
Heron Therapeutics, Inc. (HRTX)
is a Sell
Heron Therapeutics, Inc. Share Price Forecast
-
What is the Heron Therapeutics, Inc. stock price today?The Heron Therapeutics, Inc. stock price is 0.80 USD today.
-
Will HRTX stock go up or go down?Heron Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Heron Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics, Inc. is overvalued.
Is Heron Therapeutics, Inc. Stock a Buy?
-
Heron Therapeutics, Inc. share price is 0.80 while HRTX 8-day exponential moving average is 0.78, which is a Buy signal.
-
The stock price of HRTX is 0.80 while Heron Therapeutics, Inc. 20-day EMA is 0.64, which makes it a Buy.
-
Heron Therapeutics, Inc. 50-day exponential moving average is 0.39 while HRTX share price is 0.80, making it a Buy technically.
-
HRTX stock price is 0.80 and Heron Therapeutics, Inc. 200-day simple moving average is 0.12, creating a Buy signal.
Fundamental Analysis of Heron Therapeutics, Inc.
Is Heron Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Heron Therapeutics, Inc.
Should I short Heron Therapeutics, Inc. stock?
-
HRTX Moving Average Covergence Divergence (MACD) indicator is 0.17, suggesting Heron Therapeutics, Inc. is a Buy
-
Heron Therapeutics, Inc. Relative Strength Index (RSI) is 36.07, which suggest Heron Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Heron Therapeutics, Inc. is (0.77 - 1.05), which suggest Heron Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Heron Therapeutics, Inc. is (0.97 - 1.37), which suggest Heron Therapeutics, Inc. is a Sell
* Heron Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.